Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
therapeutic antibodies
|
| gptkbp:foundedIn |
2010
|
| gptkbp:founder |
gptkb:Allan_Bradley
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kymab
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
KY1005
KY1044 |
| gptkbp:parentCompany |
gptkb:Sanofi
|
| gptkbp:platform |
Kymouse
|
| gptkbp:website |
https://www.kymab.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|